Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

Recruiting Observational Study
Multi-modality Echocardiography Primary Electrical Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * primary electrical disease Exclusion Criteria: * Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease
Contacts

hanlu lv

13430268178

lv-hl@163.com

CONTACT